Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2015 Mar 5;16(3):5072-5.
doi: 10.3390/ijms16035072.

Correction: Xie, H.; et al. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors. Int. J. Mol. Sci. 2014, 15, 20927-20947

Affiliations
Published Erratum

Correction: Xie, H.; et al. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors. Int. J. Mol. Sci. 2014, 15, 20927-20947

Huiding Xie et al. Int J Mol Sci. .

Abstract

A number of sentences in the first paragraph of the introduction of [28] were copied verbatim from [21,22,25,29]. Although [21,22,25] were cited in the text, [29] was omitted and it was not made sufficiently clear that direct quotations were used. The authors wish to apologize to the authors of [21,22,25,29] and to the readers of the journal for any inconvenience.

PubMed Disclaimer

Erratum for

Similar articles

Cited by

References

    1. Winer E.P., Hudis C., Burstein H.J., Wolff A.C., Pritchard K.I., Ingle J.N., Chlebowski R.T., Gelber R., Edge S.B., Gralow J., et al. American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004. J. Clin. Oncol. 2005;23:619–629. doi: 10.1200/JCO.2005.09.121. - DOI - PubMed
    1. Perez E.A. Appraising adjuvant aromatase inhibitor therapy. Oncologist. 2006;11:1058–1069. doi: 10.1634/theoncologist.11-10-1058. - DOI - PubMed
    1. Jordan V.C., Brodie A.M.H. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids. 2007;72:7–25. doi: 10.1016/j.steroids.2006.10.009. - DOI - PMC - PubMed
    1. Brueggemeier R.W., Hackett J.C., Diaz-Cruz E.S. Aromatase inhibitors in the treatment of breast cancer. Endocr. Rev. 2005;26:331–345. doi: 10.1210/er.2004-0015. - DOI - PubMed
    1. Recanatini M., Cavalli A., Valenti P. Nonsteroidal aromatase inhibitors: Recent advances. Med. Res. Rev. 2002;22:282–304. doi: 10.1002/med.10010. - DOI - PubMed

Publication types

LinkOut - more resources